Product Information
GRALISE ER 300 MG TABLET is a brand product labeled by Almatica Pharma LLC, priced at $10.1925 per EA under NDC 52427080390. Its NADAC has been published 272 times since Apr 14, 2021.
The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Almatica Pharma LLCNDC
52427080390
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
New Drug (NDA)
FDA Application
NDA022544On Market Since
10/1/2020
Pharmacological Classes
Price Statistics
The NADAC for GRALISE ER 300 MG TABLET has been published 272 times since Apr 14, 2021, and over the history we have for it it has risen 14.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.1925 per EA |
|---|---|
| All-time high | $10.2379 (May 14, 2025) |
| All-time low | $8.8955 (Apr 14, 2021) |
| 52-week high | $10.2365 |
| 52-week low | $10.1925 |
| Median price | $10.1971 |
| Average price | $9.9160 |
| Largest weekly change | +6.0% (May 4, 2022) |
| Weeks tracked | 272 |
| Tracking since | Apr 14, 2021 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GRALISE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GRALISE ER 300 MG TABLET, manufactured by Almatica Pharma LLC, is $10.1925 per EA (NDC 52427080390), effective Jun 24, 2026.
How has the price of GRALISE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for GRALISE ER 300 MG TABLET has risen 14.6%. It has been tracked across 272 weekly CMS publications since Apr 14, 2021.
What are the highest and lowest recorded NADAC prices for GRALISE ER 300 MG TABLET?
Since Apr 14, 2021, the NADAC for GRALISE ER 300 MG TABLET has ranged from a low of $8.8955 (Apr 14, 2021) to a high of $10.2379 (May 14, 2025), with a median of $10.1971 per EA.
Are there cheaper alternatives to GRALISE ER 300 MG TABLET?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GABAPENTIN 300 MG CAPSULE, is $0.0324 per EA — about 100% below GRALISE ER 300 MG TABLET.
Who manufactures GRALISE ER 300 MG TABLET?
GRALISE ER 300 MG TABLET (NDC 52427080390) is labeled by Almatica Pharma LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification